AKS Discount Safe Harbor: Buyer, Seller, and Offeror Rules

To qualify for the Anti-Kickback Statute discount safe harbor at 42 CFR 1001.952(h), a price reduction has to satisfy every condition the regulation places on both the buyer and the seller, and the specific conditions depend on whether the buyer files cost reports with a federal healthcare program and whether the reduction is taken at the point of sale or paid later as a written rebate.¹ Missing one element strips the arrangement of protection entirely. There is no partial credit.

What Counts as a Discount

The regulation defines a discount as a reduction in the amount a buyer is charged for a good or service, based on an arm’s-length transaction. The purchase can be direct or run through a wholesaler or group purchasing organization.¹ Three pricing structures fit that definition:

On-invoice reductions, such as a contract price below list, a promotional price, or volume-tiered pricing, all shown on the invoice at the time of sale.
Prompt-pay reductions, reflected on the invoice or remittance.
Retrospective rebates, meaning price reductions whose terms are fixed and disclosed in writing to the buyer at the time of the initial purchase, even though the money changes hands later.

The written-terms requirement for rebates is where a lot of arrangements fall apart. A manufacturer that calls a customer months after a sale and offers an unplanned retroactive credit has not created a qualifying rebate. The terms need to exist in writing by the time of the initial purchase.

Buyer Requirements When the Buyer Files Cost Reports

Hospitals and other cost-reporting entities have to meet four conditions:

The discount has to be earned based on purchases of the same good or service within a single fiscal year of the buyer. A price break on product A that rewards buying unrelated product B does not qualify.
The buyer has to claim the benefit of the discount in the fiscal year it was earned or in the following fiscal year.
The buyer has to fully and accurately report the discount on the applicable cost report.
The buyer has to provide the discount information supplied by the seller or offeror when the Secretary of HHS or a state agency asks for it.¹

Cost reporting is the condition that most often gets missed. A hospital can negotiate a large rebate, document it carefully, and still fall outside the safe harbor if it doesn’t reduce its reported costs accordingly. From the government’s perspective, a discount that never lowers the reported cost isn’t a discount at all.

Buyer Requirements When the Buyer Does Not File Cost Reports

Physician practices and other buyers who submit claims rather than cost reports face two conditions:

The discount has to be applied at the time of sale, or the terms of any rebate have to be fixed and disclosed in writing to the buyer at the time of the initial sale.¹
The buyer has to provide the seller’s or offeror’s discount documentation to the government on request.

Seller Requirements

The regulation treats the entity that supplies the item and grants the price reduction as the “seller,” and treats a manufacturer or other party that offers the reduction through an intermediary (a wholesaler, for example) as an “offeror.” Both carry parallel obligations, and the specifics shift with the type of buyer.

Selling to a Cost-Reporting Buyer

Three obligations apply:

The discount has to be fully and accurately reported on the invoice or statement given to the buyer.
The seller has to inform the buyer, in a way reasonably calculated to give actual notice, of the buyer’s own reporting and disclosure duties under the safe harbor.
The seller cannot do anything that would impede the buyer’s ability to meet those obligations.¹

The non-interference piece has bite. A rebate structured so the buyer cannot readily identify the discount amount, or a contract clause asking the buyer to keep pricing confidential from the government, undermines the safe harbor for both sides.

Selling to a Non-Cost-Reporting Buyer

The obligations mirror the cost-report scenario, with one addition: the discount has to be applied at the time of sale, or the rebate terms have to be fixed and disclosed in writing at the time of the initial sale. The seller still has to inform the buyer of its reporting obligations and refrain from interfering with compliance.¹

Offeror Obligations

When a manufacturer offers a discount but is not the direct seller, the regulation imposes parallel duties. For cost-reporting buyers, the offeror has to inform the buyer of the discount’s value in writing, identify which goods or services the discount covers, and notify the buyer of its reporting obligations. For non-cost-reporting buyers, the offeror also has to ensure the rebate terms are fixed and disclosed in writing at the time of the initial sale.

HMOs and Risk-Contract Buyers

When the buyer is an HMO or competitive medical plan operating under a risk contract, neither the seller nor the offeror has to report the discount to the buyer for safe harbor purposes.¹ Risk-bearing entities absorb excess costs themselves rather than passing them to the government on a cost basis, so the reporting mechanics are handled differently.

Arrangements the Regulation Carves Out

Several price reductions that look like discounts in ordinary business terms are not “discounts” under the safe harbor and cannot claim its protection:

Cash payments and cash equivalents are excluded. The narrow exception is that qualifying rebates may be paid by check.¹
Bundled “swap” arrangements, where one product is free or reduced to induce purchase of another, are excluded. The exception applies only when both products are reimbursed by the same federal healthcare program under the same payment methodology, and the reduced charge is fully disclosed to the program and accurately reflected in the reimbursement methodology.
Price reductions given to commercial payers but not extended to Medicare, Medicaid, or other federal programs are excluded.
Routine waivers of patient copayments or deductibles are excluded, even though they function as price reductions to the patient.
Warranty-related price reductions fall under a separate warranty safe harbor at 42 CFR 1001.952(g), not this one.
Fee reductions built into personal or management services contracts are excluded from the discount definition and have to be analyzed under other safe harbors.
Manufacturer price reductions to Medicare Part D plan sponsors, whether direct or through a pharmacy benefit manager, are excluded unless the reduction is required by law.¹

The bundling exclusion is the trap most likely to catch a business team. Giving a hospital a free surgical instrument to induce purchase of a high-margin implant from the same manufacturer is a swap, not a discount, unless the two products are reimbursed under the same federal program using the same methodology. When they are (two Part B vaccines, for example), the arrangement can qualify, but the reduced charge still has to be fully disclosed to the program.

Administrative fees paid by vendors to group purchasing organizations sit outside this safe harbor as well. Those payments are governed by the separate GPO safe harbor at 42 CFR 1001.952(j), even though the discount safe harbor’s definition of “discount” contemplates purchases made through a GPO. Anyone involved in a GPO arrangement should evaluate both provisions rather than assume the discount safe harbor covers the full relationship.

What Happens If You Miss a Condition

Falling outside the safe harbor is not the same as violating the statute. The OIG has stated that “compliance with a safe harbor is voluntary; failure to satisfy a safe harbor does not mean that an arrangement is illegal.”² An unprotected arrangement is evaluated on its facts and the parties’ intent. What the safe harbor does not permit is partial credit: an arrangement either meets every element or receives none of the protection. For any discount involving meaningful dollars, satisfying every condition is worth the administrative work, because the alternative is asking a prosecutor or auditor to give the parties the benefit of the doubt on intent.

1
eCFR. 42 CFR 1001.952 – Exceptions
2
HHS Office of Inspector General. General Questions Regarding Certain Fraud and Abuse Authorities